Results 151 to 160 of about 95,906 (268)
MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1 [PDF]
, 2016 Leandro Venturutti +18 more
openalex +1 more source
Drug Design, Development and Therapy, 2018 Dehua Liao,1,2 Yujin Guo,3 Daxiong Xiang,2 Ruili Dang,3 Pengfei Xu,3 Hualin Cai,2 Lizhi Cao,1 Pei Jiang3 1Department of Pharmacy, Hunan Cancer Hospital, 2Department of Pharmacy, Institute of Clinical Pharmacy & Pharmacology, Second Xiangya Hospital,
Liao D +7 more
doaj
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs) [PDF]
, 2015 Pramudita R. Prasetyanti +12 more
openalex +1 more source
Zhongguo shiyan zhenduanxue, 2002 目的 探讨幽门螺杆菌感染与胃癌P53 、C erbB - 2的关系。方法 应用Warthin -Starry染色法检测幽门螺杆菌 ,免疫酶组化SP法检测P53 、C -erbB - 2基因蛋白。结果 Hp感染率在胃癌和癌前病变组中均高于对照组 ,而前两组差异无显著性 ,Hp感染与C erbB 2过度表达有关。P53 仅在胃癌组织中表达 ,Hp感染者与P53 过度表达有关 （P
房学东, 杨作森, 冯涛
doaj
Differential Distribution of erbB Receptors in Human Glioblastoma Multiforme: Expression of erbB3 in CD133-Positive Putative Cancer Stem Cells: Erratum [PDF]
, 2010 openalex +1 more source
胃癌p53、c-erbB-2、p21、nm23基因表达的分布特点及其临床意义
Zhongguo shiyan zhenduanxue, 2005 目的为探讨手术切除胃癌组织p53、c-erbB-2、p21、nm23联合基因产物表达检测对胃癌诊断治疗及预后判断的价值。方法应用免疫组化技术检测了手术切除胃癌组织p53c、-erbB-2、p21、nm23基因产物表达。结果p53蛋白表达阳性率为36.4%46.7%,c-erbB-2为33.3%56.8%,p21为35.1%56.7%,nm23为30.0%70.5%。在非胃癌组织中（胃,十二指肠溃疡,胃息肉,重度不典型增生）未见c-erbB-2、p21、nm23基因表达。p53c、-erbB-2 ...
陈永胜 +4 more
doaj